Meditation and Cardiovascular Risk Reduction: A Scientific Statement From the American Heart Association
- PMID: 28963100
- PMCID: PMC5721815
- DOI: 10.1161/JAHA.117.002218
Meditation and Cardiovascular Risk Reduction: A Scientific Statement From the American Heart Association
Abstract
Despite numerous advances in the prevention and treatment of atherosclerosis, cardiovascular disease remains a leading cause of morbidity and mortality. Novel and inexpensive interventions that can contribute to the primary and secondary prevention of cardiovascular disease are of interest. Numerous studies have reported on the benefits of meditation. Meditation instruction and practice is widely accessible and inexpensive and may thus be a potential attractive cost-effective adjunct to more traditional medical therapies. Accordingly, this American Heart Association scientific statement systematically reviewed the data on the potential benefits of meditation on cardiovascular risk. Neurophysiological and neuroanatomical studies demonstrate that meditation can have long-standing effects on the brain, which provide some biological plausibility for beneficial consequences on the physiological basal state and on cardiovascular risk. Studies of the effects of meditation on cardiovascular risk have included those investigating physiological response to stress, smoking cessation, blood pressure reduction, insulin resistance and metabolic syndrome, endothelial function, inducible myocardial ischemia, and primary and secondary prevention of cardiovascular disease. Overall, studies of meditation suggest a possible benefit on cardiovascular risk, although the overall quality and, in some cases, quantity of study data are modest. Given the low costs and low risks of this intervention, meditation may be considered as an adjunct to guideline-directed cardiovascular risk reduction by those interested in this lifestyle modification, with the understanding that the benefits of such intervention remain to be better established. Further research on meditation and cardiovascular risk is warranted. Such studies, to the degree possible, should utilize randomized study design, be adequately powered to meet the primary study outcome, strive to achieve low drop-out rates, include long-term follow-up, and be performed by those without inherent bias in outcome.
Keywords: AHA Scientific Statements; cardiovascular disease; cardiovascular risk; meditation; primary prevention; secondary prevention.
© 2017 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley.
Comment in
-
Editorial commentary on AHA scientific statement on meditation and cardiovascular risk reduction.J Am Soc Hypertens. 2018 Dec;12(12):e57-e58. doi: 10.1016/j.jash.2018.11.005. Epub 2018 Nov 22. J Am Soc Hypertens. 2018. PMID: 30503717 No abstract available.
Similar articles
-
Meditation for the primary and secondary prevention of cardiovascular disease.Cochrane Database Syst Rev. 2024 Feb 15;2(2):CD013358. doi: 10.1002/14651858.CD013358.pub2. Cochrane Database Syst Rev. 2024. PMID: 38358047 Review.
-
Yoga and meditation in cardiovascular disease.Clin Res Cardiol. 2014 Sep;103(9):675-80. doi: 10.1007/s00392-014-0663-9. Epub 2014 Jan 25. Clin Res Cardiol. 2014. PMID: 24464106 Review.
-
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.Circulation. 2019 Sep 10;140(11):e596-e646. doi: 10.1161/CIR.0000000000000678. Epub 2019 Mar 17. Circulation. 2019. PMID: 30879355 Free PMC article. Review. No abstract available.
-
Mediterranean-style diet for the primary and secondary prevention of cardiovascular disease.Cochrane Database Syst Rev. 2019 Mar 13;3(3):CD009825. doi: 10.1002/14651858.CD009825.pub3. Cochrane Database Syst Rev. 2019. PMID: 30864165 Free PMC article.
-
Primary Prevention Using Cholesterol-Lowering Medications in Patients Meeting New Treatment Guidelines: A Retrospective Cohort Analysis.J Manag Care Spec Pharm. 2018 Nov;24(11):1078-1085. doi: 10.18553/jmcp.2018.24.11.1078. J Manag Care Spec Pharm. 2018. PMID: 30362921 Free PMC article.
Cited by
-
Needs and Preferences for Remote-Delivered Mindfulness-Based Cognitive Therapy in Patients After Acute Coronary Syndrome: A Qualitative Study.Glob Adv Integr Med Health. 2024 Oct 5;13:27536130241288213. doi: 10.1177/27536130241288213. eCollection 2024 Jan-Dec. Glob Adv Integr Med Health. 2024. PMID: 39376785 Free PMC article.
-
Positive cardiovascular health: longitudinal investigation of sustained health behavior in a cross-lagged model.Front Public Health. 2024 Aug 22;12:1400849. doi: 10.3389/fpubh.2024.1400849. eCollection 2024. Front Public Health. 2024. PMID: 39267641 Free PMC article.
-
Effects of meditation on health promoting protective factors of persons with cardiovascular disease-a quasi-experimental pilot study with pre-post comparison.Cardiovasc Diagn Ther. 2024 Aug 31;14(4):537-546. doi: 10.21037/cdt-24-74. Epub 2024 Aug 8. Cardiovasc Diagn Ther. 2024. PMID: 39263490 Free PMC article.
-
Framingham risk scores for determination the 10-year risk of cardiovascular disease in participants with and without the metabolic syndrome: results of the Fasa Persian cohort study.BMC Endocr Disord. 2024 Jun 24;24(1):95. doi: 10.1186/s12902-024-01621-5. BMC Endocr Disord. 2024. PMID: 38915041 Free PMC article.
-
Mindfulness-Based Stress Reduction Health Insurance Coverage: If, How, and When? An Integrated Knowledge Translation (iKT) Delphi Key Informant Analysis.Mindfulness (N Y). 2024;15(5):1220-1233. doi: 10.1007/s12671-024-02366-x. Epub 2024 May 17. Mindfulness (N Y). 2024. PMID: 38817538 Free PMC article.
References
-
- Centers for Disease Control and Prevention . Heart disease facts. 2016. Available at: http://www.cdc.gov/heartdisease/facts.htm. Accessed September 23, 2016.
-
- Benjamin EJ, Blaha MJ, Chiuve SE, Cushman M, Das SR, Deo R, de Ferranti SD, Floyd J, Fornage M, Gillespie C, Isasi CR, Jimenez MC, Jordan LC, Judd SE, Lackland D, Lichtman JH, Lisabeth L, Liu S, Longenecker CT, Mackey RH, Matsushita K, Mozaffarian D, Mussolino ME, Nasir K, Neumar RW, Palaniappan L, Pandey DK, Thiagarajan RR, Reeves MJ, Ritchey M, Rodriguez CJ, Roth GA, Rosamond WD, Sasson C, Towfighi A, Tsao CW, Turner MB, Virani SS, Voeks JH, Willey JZ, Wilkins JT, Wu JHY, Alger HM, Wong SS, Muntner P; on behalf of the American Heart Association Statistics Committee and Stroke Statistics Subcommittee . Heart disease and stroke statistics—2017 update: a report from the American Heart Association [published correction appears in Circulation 2017;135:e646]. Circulation. 2017;135:e146–e603. DOI: 10.1161/CIR.0000000000000485. - DOI - PMC - PubMed
-
- Writing Committee , Smith SC Jr, Collins A, Ferrari R, Holmes DR Jr, Logstrup S, McGhie DV, Ralston J, Sacco RL, Stam H, Taubert K, Wood DA, Zoghbi WA. Our time: a call to save preventable death from cardiovascular disease (heart disease and stroke). Glob Heart. 2012;7:297–305. - PubMed
-
- World Health Organization . Global health observatory data repository. Cardiovascular diseases, deaths per 100,000. Data by country. 2016. Available at: http://apps.who.int/gho/data/node.main.A865CARDIOVASCULAR?lang=en. Accessed September 23, 2016.
-
- World Heart Federation . Deaths due to cardiovascular disease. 2016. Available at: http://www.world-heart-federation.org/cardiovascular-health/global-facts.... Accessed September 23, 2016.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
